跳至主要内容
临床试验/NCT03047889
NCT03047889Unknown不适用

A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast

Chinese Academy of Medical Sciences19 个研究点 分布在 1 个国家目标入组 4,200 人开始时间: 2016年4月最近更新:
适应症
相关药物

试验速览

阶段
不适用
入组人数
4,200
试验地点
19
主要终点
Survival status at 3 years

研究概览

简要总结

To study the epidemiological trends and characteristics for advanced breast cancer patients, to analyze these trends and report the results

详细描述

In this study, the investigators conducted a hospital-based retrospective clinical study, recruiting female advanced breast cancer patients from 14 tertiary hospitals at 7 classic geographic regions, to study the clinical epidemiologic characteristics of advanced breast cancer and the current standard of clinical diagnosis and treatment in order to provide references for standardized treatment therapy, and to improve the quality of life and prolong survival time.

To study the epidemiological trends and characteristics for advanced BC patients, to analyze these trends and report the results. To learn about the current treatment therapy for advanced BC patients in different areas in China.To provide references for standardized treatment therapy, to improve the quality of patients' life and to prolong the survival time for the advanced BC patients.To assess the different treatment therapies for advanced BC with consideration of economic cost-effectiveness

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • diagnosed as advanced breast cancer during Jan1st,2012-Dec31st,2014
  • complete with surgical pathology data, auxiliary treatment, there is a clear recurrence, transfer time, place, transfer of recurrence after treatment, and curative effect evaluation details.In any age, ethnic group cases.

排除标准

  • no available medical record

结局指标

主要结局

Survival status at 3 years

时间窗: 3 years

percentage of patients still alive at 3 years

次要结局

  • PFS(3 years)
  • Survival status at 5 years(3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Binghe Xu

Professor

Chinese Academy of Medical Sciences

研究点 (19)

Loading locations...

相似试验